{{Rsnum
|rsid=17564315
|Chromosome=2
|position=19758735
|Orientation=plus
|GMAF=0.1258
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 23.9 | 73.5
| HCB | 1.5 | 13.4 | 85.1
| JPT | 0.0 | 12.4 | 87.6
| YRI | 0.7 | 22.4 | 76.9
| ASW | 1.8 | 36.8 | 61.4
| CHB | 1.5 | 13.4 | 85.1
| CHD | 2.8 | 17.9 | 79.2
| GIH | 1.0 | 11.1 | 87.9
| LWK | 2.7 | 22.7 | 74.5
| MEX | 1.8 | 37.5 | 60.7
| MKK | 4.6 | 19.7 | 75.7
| TSI | 1.0 | 25.5 | 73.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=7E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}